Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America.
Cherrez-Ojeda I, Maurer M, Bernstein JA, Vanegas E, Felix M, Ramon GD, Ensina LF, Larco Sousa JI, Matos Benavides EE, Cardona Villa R, Latour Staffeld P, Morfin-Maciel BM, Mori J, Wilches C P, Mata VL, Cherrez A.
Cherrez-Ojeda I, et al.
World Allergy Organ J. 2019 Feb 23;12(2):100011. doi: 10.1016/j.waojou.2019.100011. eCollection 2019.
World Allergy Organ J. 2019.
PMID: 30937137
Free PMC article.